Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
05/07/1991 | CA2029338A1 Acat inhibitors |
05/07/1991 | CA1283859C Penicillamine for treating immune damaging illnesses |
05/04/1991 | CA2029268A1 Peptides aiding nerve regeneration |
05/03/1991 | CA2029216A1 Process of producing modified superoxide dismutase |
05/02/1991 | WO1991005871A1 Bispecific heteroantibodies with dual effector functions |
05/02/1991 | WO1991005802A1 Osteogenic devices |
05/02/1991 | WO1991005798A1 Compositions and methods for treating or preventing infections in canine and feline animals |
05/02/1991 | WO1991005537A1 Method of accelerating wound and ulcer healing and treating periodontal disease |
05/02/1991 | EP0425211A1 Substituted 5-((tetrazolyl)alkenyl)-imidazoles |
05/02/1991 | EP0425096A1 Polypeptides useful as blockers of calcium channels |
05/02/1991 | EP0424990A1 The manufacture and expression of large structural genes |
05/02/1991 | EP0424954A1 Pharmaceutical composition for treatment of osteoporosis |
05/02/1991 | EP0424722A2 Substituted (quinolin-2-yl-methoxy)phenyl-thioureas |
05/02/1991 | DE3936328A1 Pharmazeutische praeparate Pharmaceutical products |
05/02/1991 | CA2042577A1 Osteogenic devices |
05/02/1991 | CA2027935A1 Imidazo [4,5-b] quinolinyloxyalkanoic acid amides with enhanced water solubility |
05/01/1991 | WO1991006573A1 Inhibitor of laminin neurite promoting activity |
05/01/1991 | CA2066658A1 Inhibitor of laminin neurite promoting activity |
05/01/1991 | CA2028880A1 Condensed imidazole derivatives and processes for preparation thereof |
05/01/1991 | CA2026686A1 Method for preventing onset of type ii diabetes employing an ace inhibitor |
04/30/1991 | US5011859 Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase |
04/30/1991 | US5011838 Antiallergens, antihistamines |
04/28/1991 | WO1991006564A1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE |
04/28/1991 | WO1991006539A1 2-anilino phenylacetic acid derivatives as inhibitors of pla2 and lipoxygenase |
04/28/1991 | WO1991006538A1 Substituted benzoylbenzene-, biphenyl- and 2-oxazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase |
04/28/1991 | WO1991006537A2 Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase |
04/28/1991 | CA2070422A1 Substituted indole-, indene-, pyranoindole and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase |
04/28/1991 | CA2067138A1 Substituted benzoylbenzene-, biphenyl-and 2-oxazole-alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase |
04/28/1991 | CA2067135A1 2-anilino phenylacetic acid derivatives as inhibitors of pla2 and lipoxygenase |
04/26/1991 | CA2028314A1 Substituted (quinolin-2-yl-methoxy)phenyl-carbonylureas |
04/26/1991 | CA2027937A1 Substituted 5-¬ (tetrazolyl)alkenyl|imidazoles |
04/25/1991 | WO1991006647A1 Gastrin releasing peptide receptor |
04/25/1991 | WO1991006646A1 Solubilization and purification of the gastrin releasing peptide receptor |
04/25/1991 | WO1991006296A1 Bafilomycine macrolides for treatment of bone affecting diseases |
04/25/1991 | CA2071914A1 Bafilomycine macrolides for treatment of bone affecting diseases |
04/25/1991 | CA2069965A1 Solubilization and purification of the gastrin releasing peptide receptor |
04/25/1991 | CA2067766A1 Gastrin releasing peptide receptor |
04/24/1991 | WO1991005556A1 Camptothecin analogs as potent inhibitors of human colorectal cancer |
04/24/1991 | EP0424350A1 Derivatives of 1,4-dideoxy-1,4-imino-d-mannitol |
04/24/1991 | EP0424317A2 Pyrimidines |
04/24/1991 | EP0424311A1 Paramagnetic oil emulsion as MRI contrast agents |
04/24/1991 | EP0423943A2 Use of collagenase inhibitors in the treatment of demyelinating diseases, in particular multiple sclerosis |
04/24/1991 | EP0423845A1 A synthetic gene encoding gamma-interferon |
04/24/1991 | EP0423697A2 Emulsion of lipid containing a prostaglandin analogue |
04/24/1991 | EP0423419A1 Inhibitive agent against activity of alpha-amylase |
04/24/1991 | EP0423326A1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient |
04/24/1991 | EP0423207A1 A migration stimulating factor |
04/24/1991 | CN1050875A Aroyl-urres |
04/24/1991 | CA2067491A1 Camptothecin analogs as potent inhibitors of human colorectal cancer |
04/24/1991 | CA2026642A1 Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor |
04/24/1991 | CA2026602A1 Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor |
04/23/1991 | US5010204 Glaucoma treatment |
04/23/1991 | US5010097 Collagenase inhibitors, antiarthritic agents |
04/23/1991 | US5010095 N-(W-substituted alkyl)-'-(imidazol-4-yl)alkyl)guanidine |
04/23/1991 | US5010080 !anticarcinogenic agents |
04/23/1991 | US5010079 Indolone derivatives, their preparation and their application in therapy |
04/23/1991 | US5010073 Use of liposomes as carriers for metalloporphyrins |
04/23/1991 | US5010072 Lactamimides as calcium antagonists |
04/23/1991 | US5010065 Cyclodextrin clathrates of 5-cyanoprostacyclin derivatives and their use as pharmaceutical agents |
04/23/1991 | US5009891 Brewing extract plant seeds, vegetable grains and germs or rice bran; oil |
04/23/1991 | CA1283500C Thiopeptolide substrates for vertebrate collagenase |
04/23/1991 | CA1283499C Peptides |
04/23/1991 | CA1283422C Hydroxyvitamin d _compounds and process for preparing same |
04/23/1991 | CA1283419C Substituted di-t-butylphenols |
04/23/1991 | CA1283361C Antiviral combinations |
04/22/1991 | CA2028042A1 Substituted (quinolin-2-yl-methoxy)phenylthioureas |
04/21/1991 | WO1991005543A1 Pharmaceutical and cosmetic depigmentation compositions with a caffeic acid base |
04/20/1991 | CA2027839A1 Pyrimidines |
04/20/1991 | CA2026545A1 Paramagnetic oil emulsiions as mri contrast agents |
04/19/1991 | WO1991005565A1 BIOSYNTHETIC CONSTRUCTS OF TGF-$g(b) |
04/19/1991 | CA2070393A1 Biosynthetic constructs of tgf-beta |
04/18/1991 | WO1991005552A1 Method and compositions for inhibition of disorders associated with oxidative damage |
04/18/1991 | WO1991004977A1 Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof |
04/18/1991 | WO1991004748A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
04/18/1991 | WO1991004673A1 Feed additive for poultry, poultry feed and method of poultry feeding |
04/18/1991 | WO1991004664A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
04/18/1991 | CA2067803A1 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof |
04/18/1991 | CA2066046A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
04/17/1991 | EP0423015A1 Effervescent nails composition |
04/17/1991 | EP0422878A1 (2-Imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
04/17/1991 | EP0422846A2 Aroyl-ureas |
04/17/1991 | EP0422697A1 A consensus leukocyte interferon and a gene encoding it |
04/17/1991 | EP0422566A1 A process for the preparation of 3-(L-pyroglutamyl)-L-thiazolidine-4-carboxylic acid derivatives |
04/17/1991 | EP0422186A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
04/17/1991 | EP0422104A1 Angiogenic potentiating peptides which potentiate angiogenic factors |
04/17/1991 | EP0422079A1 Tricyclic lipoxygenase inhibiting compounds, compositions, methods of use |
04/16/1991 | US5008374 IL-1α derivatives and drugs |
04/16/1991 | US5008292 Pesticidal method |
04/16/1991 | US5008283 Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
04/16/1991 | US5008273 Amino acid derivatives and their pharmaceutical use |
04/16/1991 | US5008272 Antagonists; useful in treatment of psychotic disorders, central nervous system disorder; antidepressant |
04/16/1991 | US5008268 2-aminopyrimidinone derivatives |
04/16/1991 | US5008266 4(3H)-quinazolinone derivatives and pharmaceutical compositions |
04/16/1991 | US5008119 Increasing metallothioneim level in host |
04/16/1991 | CA1283119C Hydroxyacetic acid derivatives for the treatment of diabetic complications |
04/15/1991 | WO1991005783A1 Heterocyclic compounds |
04/14/1991 | WO1991005797A1 Methods and compositions for healing bone |
04/14/1991 | WO1991005754A2 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
04/14/1991 | CA2067505A1 Methods and compositions for healing bone |
04/14/1991 | CA2044162A1 Long-chained fatty alcohol derivatives, their applications, specifically as cytotrphic and cytoprotecting molecules, and pharmaceutical compounds containing same |